Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

USA - NYSE:XHR - US9840171030 - REIT

14.82 USD
+0.1 (+0.68%)
Last: 9/15/2025, 12:14:10 PM
Fundamental Rating

5

Taking everything into account, XHR scores 5 out of 10 in our fundamental rating. XHR was compared to 130 industry peers in the Diversified REITs industry. XHR has only an average score on both its financial health and profitability. XHR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year XHR was profitable.
XHR had a positive operating cash flow in the past year.
In multiple years XHR reported negative net income over the last 5 years.
Of the past 5 years XHR 4 years had a positive operating cash flow.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

XHR's Return On Assets of 2.17% is fine compared to the rest of the industry. XHR outperforms 67.69% of its industry peers.
XHR has a Return On Equity of 5.14%. This is in the better half of the industry: XHR outperforms 66.15% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.99%, XHR is in line with its industry, outperforming 58.46% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for XHR is in line with the industry average of 3.05%.
The last Return On Invested Capital (2.99%) for XHR is above the 3 year average (2.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.17%
ROE 5.14%
ROIC 2.99%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Profit Margin of XHR (5.81%) is comparable to the rest of the industry.
XHR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.66%, XHR is doing worse than 78.46% of the companies in the same industry.
XHR's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.73%, XHR is not doing good in the industry: 73.85% of the companies in the same industry are doing better.
XHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.66%
PM (TTM) 5.81%
GM 54.73%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XHR is destroying value.
XHR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for XHR has been reduced compared to 5 years ago.
XHR has a better debt/assets ratio than last year.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.73, we must say that XHR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XHR (0.73) is better than 63.85% of its industry peers.
XHR has a debt to FCF ratio of 56.29. This is a negative value and a sign of low solvency as XHR would need 56.29 years to pay back of all of its debts.
The Debt to FCF ratio of XHR (56.29) is better than 60.77% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that XHR has dependencies on debt financing.
XHR has a Debt to Equity ratio (1.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 56.29
Altman-Z 0.73
ROIC/WACC0.4
WACC7.41%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.64 indicates that XHR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.64, XHR is in the better half of the industry, outperforming 71.54% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that XHR should not have too much problems paying its short term obligations.
XHR's Quick ratio of 1.64 is fine compared to the rest of the industry. XHR outperforms 71.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

XHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 186.36%, which is quite impressive.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.70% yearly.
XHR shows a small growth in Revenue. In the last year, the Revenue has grown by 4.81%.
XHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.99% yearly.
EPS 1Y (TTM)186.36%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%273.33%
Revenue 1Y (TTM)4.81%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%5.38%

3.2 Future

XHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.53% yearly.
XHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.17% yearly.
EPS Next Y169.33%
EPS Next 2Y16.05%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year3.62%
Revenue Next 2Y3.23%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.52, XHR is valued on the expensive side.
Based on the Price/Earnings ratio, XHR is valued cheaper than 82.31% of the companies in the same industry.
XHR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 73.37, XHR can be considered very expensive at the moment.
XHR's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.73. XHR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 23.52
Fwd PE 73.37
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XHR indicates a somewhat cheap valuation: XHR is cheaper than 76.15% of the companies listed in the same industry.
XHR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 56.13
EV/EBITDA 11.34
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XHR's earnings are expected to grow with 42.53% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y16.05%
EPS Next 3Y42.53%

4

5. Dividend

5.1 Amount

XHR has a Yearly Dividend Yield of 3.68%.
Compared to an average industry Dividend Yield of 6.66, XHR is paying slightly less dividend.
XHR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has been paying a dividend for at least 10 years, so it has a reliable track record.
XHR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-15.89%
Div Incr Years2
Div Non Decr Years2
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

40.97% of the earnings are spent on dividend by XHR. This is a bit on the high side, but may be sustainable.
DP40.97%
EPS Next 2Y16.05%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (9/15/2025, 12:14:10 PM)

14.82

+0.1 (+0.68%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners98.26%
Inst Owner Change-1.64%
Ins Owners0.94%
Ins Owner Change0%
Market Cap1.42B
Analysts78
Price Target15.3 (3.24%)
Short Float %4.16%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP40.97%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.14)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.72%
Min EPS beat(2)81.79%
Max EPS beat(2)163.65%
EPS beat(4)3
Avg EPS beat(4)13.88%
Min EPS beat(4)-199.01%
Max EPS beat(4)163.65%
EPS beat(8)6
Avg EPS beat(8)71.52%
EPS beat(12)7
Avg EPS beat(12)103.41%
EPS beat(16)10
Avg EPS beat(16)88.82%
Revenue beat(2)2
Avg Revenue beat(2)4.02%
Min Revenue beat(2)3.88%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.12%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.16%
Revenue beat(8)3
Avg Revenue beat(8)0.33%
Revenue beat(12)5
Avg Revenue beat(12)0.23%
Revenue beat(16)9
Avg Revenue beat(16)1.91%
PT rev (1m)5.63%
PT rev (3m)10.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-21.57%
EPS NY rev (3m)-21.57%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 23.52
Fwd PE 73.37
P/S 1.32
P/FCF 56.13
P/OCF 8.21
P/B 1.17
P/tB 1.17
EV/EBITDA 11.34
EPS(TTM)0.63
EY4.25%
EPS(NY)0.2
Fwd EY1.36%
FCF(TTM)0.26
FCFY1.78%
OCF(TTM)1.8
OCFY12.18%
SpS11.23
BVpS12.7
TBVpS12.65
PEG (NY)0.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 5.14%
ROCE 3.78%
ROIC 2.99%
ROICexc 3.19%
ROICexgc 3.24%
OM 9.66%
PM (TTM) 5.81%
GM 54.73%
FCFM 2.35%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 56.29
Debt/EBITDA 6.06
Cap/Depr 112.83%
Cap/Sales 13.73%
Interest Coverage 1.19
Cash Conversion 73.66%
Profit Quality 40.49%
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 0.73
F-Score8
WACC7.41%
ROIC/WACC0.4
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.36%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%273.33%
EPS Next Y169.33%
EPS Next 2Y16.05%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)4.81%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%5.38%
Revenue Next Year3.62%
Revenue Next 2Y3.23%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y20.56%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year195.4%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-76.27%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y-8.64%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%